ATE489945T1 - Acrylzusammensetzungen zur enterischen beschichtung - Google Patents

Acrylzusammensetzungen zur enterischen beschichtung

Info

Publication number: ATE489945T1
Authority: AT; Austria
Prior art keywords: percent; weight; vinyl; moiety; acrylic resin
Prior art date: 2000-02-10

Application number

AT01910485T

Other languages

English (en)

Inventor

Ramireddy Chittamuru

George Reyes

Thomas Farrell

Charles Vesey

Dev Mehra

Hans-Ulrich Petereit

Klaus Lehmann

Original Assignee

Bpsi Holdings Inc

Evonik Roehm Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-02-10

Filing date

2001-02-09

Publication date

2010-12-15

2001-02-09 Application filed by Bpsi Holdings Inc, Evonik Roehm Gmbh filed Critical Bpsi Holdings Inc

2001-02-09 Priority claimed from PCT/US2001/004167 external-priority patent/WO2001058429A1/en

2010-12-15 Application granted granted Critical

2010-12-15 Publication of ATE489945T1 publication Critical patent/ATE489945T1/de

Links

239000000203 mixture Substances 0.000 title abstract 2
239000002702 enteric coating Substances 0.000 title 1
238000009505 enteric coating Methods 0.000 title 1
239000004925 Acrylic resin Substances 0.000 abstract 2
229920000178 Acrylic resin Polymers 0.000 abstract 2
125000002573 ethenylidene group Chemical group [*]=C=C([H])[H] 0.000 abstract 2
150000003839 salts Chemical class 0.000 abstract 2
125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 abstract 2
229920002554 vinyl polymer Polymers 0.000 abstract 2
230000002378 acidificating effect Effects 0.000 abstract 1
230000003113 alkalizing effect Effects 0.000 abstract 1
125000005250 alkyl acrylate group Chemical group 0.000 abstract 1
230000015572 biosynthetic process Effects 0.000 abstract 1
125000002843 carboxylic acid group Chemical group 0.000 abstract 1
239000003795 chemical substances by application Substances 0.000 abstract 1
239000011248 coating agent Substances 0.000 abstract 1
238000000576 coating method Methods 0.000 abstract 1
239000007888 film coating Substances 0.000 abstract 1
238000009501 film coating Methods 0.000 abstract 1
231100000252 nontoxic Toxicity 0.000 abstract 1
230000003000 nontoxic effect Effects 0.000 abstract 1
239000000843 powder Substances 0.000 abstract 1
239000011347 resin Substances 0.000 abstract 1
229920005989 resin Polymers 0.000 abstract 1
239000000725 suspension Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2893—Tablet coating processes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2813—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Inorganic Chemistry (AREA)
Medicinal Preparation (AREA)
Paints Or Removers (AREA)

AT01910485T 2000-02-10 2001-02-09 Acrylzusammensetzungen zur enterischen beschichtung ATE489945T1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US09/501,866 US6420473B1 (en)	2000-02-10	2000-02-10	Acrylic enteric coating compositions
US09/766,859 US20010022972A1 (en)	2000-02-10	2001-01-19	Acrylic enteric coating compositions
PCT/US2001/004167 WO2001058429A1 (en)	2000-02-10	2001-02-09	Acrylic enteric coating compositions

Publications (1)

Publication Number	Publication Date
ATE489945T1 true ATE489945T1 (de)	2010-12-15

Family

ID=23995328

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT01910485T ATE489945T1 (de)	2000-02-10	2001-02-09	Acrylzusammensetzungen zur enterischen beschichtung

Country Status (11)

Country	Link
US (2)	US6420473B1 (de)
JP (1)	JP4914552B2 (de)
AT (1)	ATE489945T1 (de)
CO (1)	CO5280227A1 (de)
DE (1)	DE60143567D1 (de)
ES (1)	ES2356706T3 (de)
IL (1)	IL150850A (de)
SA (1)	SA01210744B1 (de)
SI (1)	SI1272165T1 (de)
TW (1)	TWI283183B (de)
ZA (1)	ZA200205843B (de)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8071128B2 (en) *	1996-06-14	2011-12-06	Kyowa Hakko Kirin Co., Ltd.	Intrabuccally rapidly disintegrating tablet and a production method of the tablets
DE10220470A1 (de) *	2002-04-30	2003-11-20	Roehm Gmbh	ph-sensitives Polymer
CA2396237A1 (en) *	2000-01-07	2001-07-19	Jacob Gabriel Michael	Selective activation of a th1 or th2 lymphocyte regulated immune response
GB0011903D0 (en) *	2000-05-18	2000-07-05	Astrazeneca Ab	Combination chemotherapy
DE10044642A1 (de) *	2000-09-08	2002-03-21	Tfl Ledertechnik Gmbh & Co Kg	Gefärbtes Leder und Färbeverfahren für gegerbtes Leder
US20030070584A1 (en)	2001-05-15	2003-04-17	Cynthia Gulian	Dip coating compositions containing cellulose ethers
US20030072731A1 (en) *	2001-05-15	2003-04-17	Cynthia Gulian	Dip coating compositions containing starch or dextrin
US20030072729A1 (en) *	2001-05-15	2003-04-17	Christopher Szymczak	Simethicone as weight gain enhancer
US8309118B2 (en)	2001-09-28	2012-11-13	Mcneil-Ppc, Inc.	Film forming compositions containing sucralose
US9358214B2 (en)	2001-10-04	2016-06-07	Adare Pharmaceuticals, Inc.	Timed, sustained release systems for propranolol
US20030203019A1 (en) *	2002-04-30	2003-10-30	Cornelius John Mark	Coated conditioners for use in foods and pharmaceuticals
US7429619B2 (en)	2002-08-02	2008-09-30	Mcneil Consumer Healthcare	Polyacrylic film forming compositions
US8367111B2 (en) *	2002-12-31	2013-02-05	Aptalis Pharmatech, Inc.	Extended release dosage forms of propranolol hydrochloride
AU2004212960A1 (en) *	2003-02-20	2004-09-02	Bpsi Holdings, Inc.	Pearlescent film coating systems and substrates coated therewith
US20040166211A1 (en) *	2003-02-20	2004-08-26	Gesford Pamela K.	Shellac-based film coatings containing pearlescent pigments and edible articles coated therewith
US20040166214A1 (en) *	2003-02-20	2004-08-26	Gesford Pamela K.	Film coatings containing pearlescent pigments and edible articles coated therewith
EP1624859A4 (de) *	2003-05-06	2010-06-23	Bpsi Holdings Inc	Verfahren zur herstellung von thermogeformten zusammensetzungen mit acrylpolymerbindemitteln, pharmazeutische dosierformen und verfahren zu ihrer herstellung
CL2004000983A1 (es) *	2003-05-08	2005-03-04	Altana Pharma Ag	Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y
RU2351315C2 (ru) *	2003-07-24	2009-04-10	Смитклайн Бичам Корпорейшн	Пленки, растворяющиеся в полости рта
RU2332865C2 (ru) *	2003-10-28	2008-09-10	Дж. М. Хьюбер Корпорейшн	Средства для кондиционирования с покрывающим слоем для пищевых продуктов и фармацевтических препаратов
EP1729742A1 (de)	2004-03-31	2006-12-13	BPSI Holdings, Inc.	Magensaftresistente überzüge für oral aufnehmbare substrate
US20080126195A1 (en)	2004-07-22	2008-05-29	Ritter Andrew J	Methods and Compositions for Treating Lactose Intolerance
EP2036546B1 (de)	2004-08-23	2018-10-10	PEJO Iserlohn Heilmittel-und Diät-GmbH & Co.KG	Psychostimulantium mit einer pharmazeutischen Zusammensetzung
US8747895B2 (en)	2004-09-13	2014-06-10	Aptalis Pharmatech, Inc.	Orally disintegrating tablets of atomoxetine
US9884014B2 (en)	2004-10-12	2018-02-06	Adare Pharmaceuticals, Inc.	Taste-masked pharmaceutical compositions
ES2409347T3 (es) *	2004-10-21	2013-06-26	Aptalis Pharmatech, Inc.	Composiciones farmacéuticas de sabor enmascarado con agentes porogénicos gastrosolubles
US20060105038A1 (en) *	2004-11-12	2006-05-18	Eurand Pharmaceuticals Limited	Taste-masked pharmaceutical compositions prepared by coacervation
TW200626185A (en) *	2004-12-17	2006-08-01	Bpsi Holdings Inc	Enteric film coating composition containing entericpolymer micronized with detackifier
KR100582347B1 (ko) *	2004-12-30	2006-05-22	한미약품 주식회사	3-하이드록시-3-메틸글루타릴 조효소 ａ 환원효소 억제제및 고혈압 치료제의 복합제제 및 그의 제조방법
US9161918B2 (en)	2005-05-02	2015-10-20	Adare Pharmaceuticals, Inc.	Timed, pulsatile release systems
AR055099A1 (es) *	2005-07-28	2007-08-08	Alza Corp	Formulaciones liquidas para la administracion controlada de derivados de bencisoxazol
US20060165776A1 (en) *	2005-08-31	2006-07-27	Ramesh Sesha	Antidepressant oral pharmaceutical compositions
US20100029788A1 (en) *	2006-09-29	2010-02-04	John Pelesko	Wet edible pearlescent film coatings
EP2099312B1 (de) *	2006-12-14	2016-05-04	Sensient Colors LLC	Perlmuttpigmentzusammensetzungen sowie verfahren zu ihrer herstellung und verwendung
US20110033528A1 (en) *	2009-08-05	2011-02-10	Poniard Pharmaceuticals, Inc.	Stabilized picoplatin oral dosage form
RU2010123692A (ru) *	2007-11-13	2011-12-20	Геркулес Инкорпорейтед (Us)	Диспергируемая в воде композиция энтеросолюбильного покрытия для нутрицевтических и фармацевтических лекарственных форм
US20110223248A1 (en) *	2007-12-12	2011-09-15	Ritter Pharmaceuticals, Inc.	Methods and compositions for treating lactose intolerance
CA2712282A1 (en) *	2008-01-25	2009-07-30	Alphapharm Pty Ltd	Delayed release pharmaceutical composition of duloxetine
JP5466379B2 (ja) *	2008-06-30	2014-04-09	ツキオカフィルム製薬株式会社	フィルム状製剤及びフィルム状製剤の製造方法
SG2014014435A (en) *	2009-02-24	2014-07-30	Ritter Pharmaceuticals Inc	Prebiotic formulations and methods of use
RU2011150266A (ru) *	2009-05-12	2013-06-20	БиПиЭсАй ХОЛДИНГЗ, ЭлЭлСи.	Пленочные покрытия, содержащие тонкодисперсные вещества против клейкости, и субстраты, покрытые этой пленкой
WO2010132204A1 (en)	2009-05-12	2010-11-18	Bpsi Holdings, Llc.	Enhanced moisture barrier immediate release film coating systems and substrates coated therewith
EP2459177A1 (de) *	2009-07-30	2012-06-06	Evonik Röhm GmbH	Zusammensetzung aus einem anionischen polymer-material und dem salz einer gesättigten monocarbonsäure mit 6 bis 22 kohlenstoffatomen
RU2563623C2 (ru)	2009-12-02	2015-09-20	Апталис Фарма Лимитед	Микрокапсулы фексофенадина и содержащие их композиции
US20110212171A1 (en) *	2010-01-08	2011-09-01	Eurand, Inc.	Taste masked topiramate composition and an orally disintegrating tablet comprising the same
WO2011137249A1 (en) *	2010-04-28	2011-11-03	Ritter Pharmaceuticals, Inc.	Prebiotic formulations and methods of use
WO2013045352A1 (de)	2011-09-30	2013-04-04	Basf Se	Verfahren zur herstellung von festen pigmenthaltigen filmüberzugsmitteln in form von granulaten auf basis von magensaftresistenten filmbildnern für pharmazeutische dosierungsformen
US20140141075A1 (en)	2012-11-21	2014-05-22	Warner Chilcott Company, Llc	5-aminosalicylic acid capsule formulation
US9233074B2 (en) *	2013-03-01	2016-01-12	Bpsi Holdings, Llc	Delayed release film coatings containing calcium silicate and substrates coated therewith
US20170216328A1 (en)	2014-04-04	2017-08-03	Ritter Pharmaceuticals, Inc.	Methods and compositions for microbiome alteration
EP4066846A1 (de)	2015-11-03	2022-10-05	The Brigham & Women's Hospital, Inc.	Therapeutische mikrobiota zur behandlung und/oder vorbeugung von lebensmittelallergie
KR20190050784A (ko) *	2016-09-07	2019-05-13	사니오나 에이/에스	테소펜신 조성물
WO2019118984A2 (en)	2017-12-15	2019-06-20	Solarea Bio, Inc.	Microbial compositions and methods for treating type 2 diabetes, obesity, and metabolic syndrome
US10758489B2 (en)	2018-04-12	2020-09-01	Bpsi Holdings Llc	Acidifying coatings and disintegration-resistant substrates coated therewith
EP3610862A1 (de) *	2018-08-14	2020-02-19	Apillet APS	Neuartige orale zusammensetzung
CA3111795A1 (en)	2018-09-05	2020-03-12	Solarea Bio, Inc.	Methods and compositions for treating musculoskeletal diseases
US11980647B2 (en)	2018-09-05	2024-05-14	Solarea Bio, Inc.	Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause
US11122828B2 (en)	2018-11-05	2021-09-21	MarvelBiome, Inc.	Microbial compositions comprising ellagitannin and methods of use
EP3986163A2 (de)	2019-06-19	2022-04-27	Solarea Bio, Inc.	Mikrobielle zusammensetzungen und verfahren zur herstellung von aufgewerteten probiotischen zusammenstellungen
CA3150161A1 (en)	2019-08-13	2021-02-18	Darlene E. MCCORD	Non-activated, amorphous, ph neutral, two-part bedside-ready clay delivery system that treats pathogen infections in humans and animals
WO2023076855A1 (en)	2021-10-25	2023-05-04	Mccord Darlene E	Coated medicinal clay compositions, pharmaceutical compositions, and delivery of cation sources and methods of use thereof
CA3238788A1 (en)	2021-11-22	2023-05-25	Eric Michael Schott	Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause
US20230190834A1 (en)	2021-12-21	2023-06-22	Solarea Bio, Inc.	Immunomodulatory compositions comprising microbial entities
IL320134A (en)	2022-12-09	2025-06-01	Evonik Operations Gmbh	Sustained release formulation with resistance to gastric conditions in fed state
WO2025064645A1 (en)	2023-09-19	2025-03-27	Flagship Pioneering Innovations Vi, Llc	Compositions and methods for treating inflammatory bowel disease
WO2025064621A1 (en)	2023-09-19	2025-03-27	Flagship Pioneering Innovations Vi, Llc	Compositions and methods for treating colorectal cancer

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4543370A (en)	1979-11-29	1985-09-24	Colorcon, Inc.	Dry edible film coating composition, method and coating form
US4683256A (en)	1980-11-06	1987-07-28	Colorcon, Inc.	Dry edible film coating composition, method and coating form
DE3208791A1 (de) *	1982-03-11	1983-09-22	Röhm GmbH, 6100 Darmstadt	Verfahren zum ueberziehen von arzneiformen mittes eines in wasser dispergierten ueberzugsmittels
ZA86252B (en) *	1985-01-30	1986-09-24	Warner Lambert Co	Coated dosage forms
US4855402A (en) *	1985-11-25	1989-08-08	The Goodyear Tire & Rubber Company	Self-emulsifiable resin powder
US5914132A (en)	1993-02-26	1999-06-22	The Procter & Gamble Company	Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
EP0621032B1 (de) *	1993-04-23	2000-08-09	Novartis AG	Wirkstoffabgabevorrichtung mit gesteuerter Freigabe
JP2917799B2 (ja)	1994-03-11	1999-07-12	田辺製薬株式会社	消化管内適所放出型製剤
US5733575A (en) *	1994-10-07	1998-03-31	Bpsi Holdings, Inc.	Enteric film coating compositions, method of coating therewith, and coated forms
DE19626045C2 (de) *	1996-06-28	1998-12-03	Klinge Co Chem Pharm Fab	Stabile Arzneiform zur oralen Verabreichung, welche Omeprazol als aktiven Wirkstoff enthält, sowie Verfahren zur Herstellung derselben
DE19637082A1 (de) *	1996-09-12	1998-03-19	Boehringer Mannheim Gmbh	Schnellzerfallende Pellets
US6174548B1 (en) *	1998-08-28	2001-01-16	Andrx Pharmaceuticals, Inc.	Omeprazole formulation
UA73092C2 (uk) *	1998-07-17	2005-06-15	Брістол-Майерс Сквібб Компані	Таблетка з ентеросолюбільним покриттям і спосіб її приготування

2000
- 2000-02-10 US US09/501,866 patent/US6420473B1/en not_active Expired - Lifetime
2001
- 2001-01-19 US US09/766,859 patent/US20010022972A1/en not_active Abandoned
- 2001-02-06 TW TW090102449A patent/TWI283183B/zh not_active IP Right Cessation
- 2001-02-09 DE DE60143567T patent/DE60143567D1/de not_active Expired - Lifetime
- 2001-02-09 AT AT01910485T patent/ATE489945T1/de active
- 2001-02-09 JP JP2001557540A patent/JP4914552B2/ja not_active Expired - Fee Related
- 2001-02-09 ES ES01910485T patent/ES2356706T3/es not_active Expired - Lifetime
- 2001-02-09 SI SI200130987T patent/SI1272165T1/sl unknown
- 2001-02-09 CO CO01009749A patent/CO5280227A1/es active IP Right Grant
- 2001-02-27 SA SA01210744A patent/SA01210744B1/ar unknown
2002
- 2002-07-22 IL IL150850A patent/IL150850A/en unknown
- 2002-07-22 ZA ZA200205843A patent/ZA200205843B/en unknown

Also Published As

Publication number	Publication date
US20010022972A1 (en)	2001-09-20
DE60143567D1 (de)	2011-01-13
CO5280227A1 (es)	2003-05-30
IL150850A (en)	2007-06-17
ES2356706T3 (es)	2011-04-12
US6420473B1 (en)	2002-07-16
SA01210744B1 (ar)	2006-10-29
SI1272165T1 (sl)	2011-03-31
JP4914552B2 (ja)	2012-04-11
JP2003522139A (ja)	2003-07-22
ZA200205843B (en)	2003-10-22
TWI283183B (en)	2007-07-01

Publication	Publication Date	Title
ATE489945T1 (de)	2010-12-15	Acrylzusammensetzungen zur enterischen beschichtung
ATE376414T1 (de)	2007-11-15	Pellet formulierung mit gesteuerter freisetzung
BR0002138A (pt)	2000-10-31	Composição de polìmero, processo para aumentar o tempo de abertura de uma composição cimentosa aquosa, e, uso de uma composição de polìmero
NZ572760A (en)	2012-11-30	A delayed release drug formulation comprising a coating comprising a low amylose starch and a Eudragit acrylate polymer
DE50202938D1 (de)	2005-06-02	Halogenfreie flammgeschützte polyester
AU6197499A (en)	2000-04-26	Coated medicament forms with controlled active substance release
RU92016217A (ru)	1995-05-20	Двойные ингибиторы no синтазы и циклооксигеназы, способ их получения и фармацевтическая композиция на их основе
JP2008536020A5 (de)	2011-06-16
CA2397832A1 (en)	2001-08-16	Acrylic enteric coating compositions
TR200801943T1 (tr)	2008-09-22	İnce tabaka oluşturan yayıcı maddeler.
BR0311642A (pt)	2005-03-01	Formulação de divalproex de sódio de liberação aumentada
ATE414745T1 (de)	2008-12-15	Wässrige beschichtungszusammensetzungen
ATE464043T1 (de)	2010-04-15	Pharmazeutische zusammensetzung enthaltend l- arginin
MXPA05003283A (es)	2005-11-23	Composicion de polimero y formas de dosis que comprenden la misma.
JP2008088394A5 (de)	2009-08-06
EA200200627A1 (ru)	2002-12-26	Адгезионные композиции для зубных протезов, включающие полимерный активатор
CA2797809A1 (en)	2011-11-03	Enteric tablet
JPS54138036A (en)	1979-10-26	Remoistening adhesive
AR034545A1 (es)	2004-03-03	Composiciones de recubrimiento entericas acrilicas
NO884226D0 (no)	1988-09-23	Korrosjonsbeskyttelsesmiddel.
JP2006104141A5 (de)	2006-12-28
ES2108575T3 (es)	1997-12-16	Procedimiento para la obtencion de copolimeros, formados por esteres vinilicos y acidos carboxilicos monoetilenicamente insaturados y su empleo.
BR9916021A (pt)	2001-10-30	Composições farmacêuticas contendo quinaprilmagnésio
JP2000313843A5 (de)	2007-08-30
JPS52136288A (en)	1977-11-14	Preparation of water-soluble resins